TransMedics Group (TMDX) PT Lowered to $92 at JPMorgan

August 5, 2026 8:17 AM

JPMorgan analyst Allen Gong lowered the price target on TransMedics Group (NASDAQ: TMDX) to $92.00 (from $100.00) while maintaining a Neutral rating.

No results found